130 million people worldwide live with chronic hepatitis C

Gilead wins India patent for blockbuster Hepatitis drug

India has granted a patent to US pharmaceutical giant Gilead for a blockbuster Hepatitis C drug, in a U-turn activists said could potentially stop affordable copies reaching millions of people in other countries. The drug, Sovaldi, which costs $1,000 (£690) a pill in the United States,

‘One You’ health campaign asks ‘How are You’?

New ‘One You’ health campaign asks ‘How are You’? Modern day life makes it hard for pe ...

» read more

E-cigarettes are 95 per cent less harmful than tobacco, finds UK study

ELECTRONIC cigarettes are around 95 per cent less harmful than tobacco and should be promoted as a tool to help ...

» read more

India tightens rules on cigarettes, tobacco branding

TOBACCO companies in India will have to stamp health warnings across 85 per cent of the surface of cigarette pac ...

» read more

Quick, short runs pack health benefits: US study

GOING out for a quick, daily run may be just as effective as a long-distance jaunt when it comes to prolonging y ...

» read more

TVs, cars, computers linked to obesity in poor nations

  IN LOW-INCOME countries, people with cars, televisions and computers at home are far more likely to b ...

» read more